These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1628051)

  • 1. Symptoms after accelerated immunisation.
    Ramsay ME; Rao M; Begg NT
    BMJ; 1992 Jun; 304(6841):1534-6. PubMed ID: 1628051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
    BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events and antibody response to accelerated immunisation in term and preterm infants.
    Ramsay ME; Miller E; Ashworth LA; Coleman TJ; Rush M; Waight PA
    Arch Dis Child; 1995 Mar; 72(3):230-2. PubMed ID: 7741570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of immunisation against diphtheria, pertussis and tetanus (DPT) in relation to sudden infant death syndrome.
    Essery SD; Raza MW; Zorgani A; MacKenzie DA; James VS; Weir DM; Busuttil A; Hallam N; Blackwell C
    FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):183-92. PubMed ID: 10443507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial.
    Langley JM; Halperin SA; Rubin E; White C; McNeil S; Mutch J; Mackinnon-Cameron D; Smith B
    Pediatr Infect Dis J; 2012 Feb; 31(2):189-92. PubMed ID: 22173143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent and general practitioner preferences for infant immunisation. Reactogenicity or multiple injections?
    Bartlett MJ; Burgess MA; McIntyre PB; Heath TC
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S22-7. PubMed ID: 9988924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diphtheria prevention among children in Denmark].
    Hansen KG; Rønne T
    Nord Med; 1995; 110(2):48-9, 52. PubMed ID: 7854910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.
    Scheifele DW; Meekison W; Grace M; Barreto L; Carter AO; Mitchell L; Farley J
    CMAJ; 1991 Sep; 145(6):641-7. PubMed ID: 1893319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: A systematic review.
    Patterson J; Kagina BM; Gold M; Hussey GD; Muloiwa R
    Vaccine; 2018 Sep; 36(40):6007-6016. PubMed ID: 30143272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation.
    Bell F; Martin A; Blondeau C; Thornton C; Chaplais J; Finn A
    Arch Dis Child; 1996 Oct; 75(4):298-303. PubMed ID: 8984914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey to establish the incidence of minor side effects in infants following protective immunization.
    Floyd CB; Freeling P
    J R Coll Gen Pract; 1989 Sep; 39(326):359-63. PubMed ID: 2558185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with diphtheria, tetanus, and pertussis immunisation in Bangladesh: factors identifying high risk groups.
    Zeitlyn S; Rahman AK; Nielsen BH; Gomes M; Kofoed PE; Mahalanabis D
    BMJ; 1992 Mar; 304(6827):606-9. PubMed ID: 1559089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.